Article Text

Download PDFPDF
CASE REPORT
Vancomycin-induced thrombocytopaenia in a patient with severe pancreatitis
  1. Simon P Rowland1,
  2. Iain Rankin2,
  3. Hemant Sheth3
  1. 1Imperial College London, London, UK
  2. 2Ealing Hospital NHS Trust, London, UK
  3. 3Upper GI Surgery, Ealing Hospital NHS Trust, London, UK
  1. Correspondence to Simon P Rowland, simon.rowland05{at}imperial.ac.uk

Summary

Vancomycin-induced thrombocytopenia is a rare side effect of a commonly used drug that may cause life-threatening disease. A 51-year-old man was treated for an episode of acute severe alcohol-induced pancreatitis complicated by development of a peripancreatic fluid collection. He developed fever of unknown origin and was treated with intravenous vancomycin and piperacillin with tazobactam. On day 6 of vancomycin therapy his platelet count dropped to 46×109/L (237×109/L on day 1 of treatment) and by day 8 of therapy platelets had fallen to a nadir of 9×109/L. The patient at this stage displayed a florid purpuric rash and haematoma formation on attempted intravenous cannulation. A clinical diagnosis of vancomycin-induced thrombocytopaenia was made and the drug withdrawn. After 3 days a significant improvement in the platelet count was noted, rising to 56 × 109/L. Immunofluorescence testing (PIFT) ruled out teicoplanin and heparin as causes of drug-induced thrombocytopenia.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.